Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Pharmacokinetics of nasally administered tobramycin and colistin in Cystic Fibrosis

Trial Profile

Pharmacokinetics of nasally administered tobramycin and colistin in Cystic Fibrosis

Completed
Phase of Trial: Phase I

Latest Information Update: 10 Nov 2015

At a glance

  • Drugs Tobramycin (Primary) ; Colistin
  • Indications Bacterial infections; Cystic fibrosis
  • Focus Pharmacokinetics
  • Acronyms SPOEL
  • Most Recent Events

    • 10 Nov 2015 Status changed from not yet recruiting to completed as per results published in Journal of Antimicrobial Chemotherapy
    • 12 Jun 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top